IBO insider trading
NYSE American HealthcareIMPACT BIOMEDICAL INC.: insider trade history from SEC Form 4 filings.
About IMPACT BIOMEDICAL INC.
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc
Company website: www.impactbiomedinc.com
IBO insider activity at a glance
FilingIQ tracks 42 insider transactions for IBO in filings since Sep 18, 2024. The most recent transaction is dated Sep 24, 2026.
Across the full history, 8 open-market purchases
and 34 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on IBO insider trades is 60.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest IBO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for IBO?
- FilingIQ tracks 42 Form 4 insider transactions for IBO (IMPACT BIOMEDICAL INC.), covering filings from Sep 18, 2024 onwards. 3 of those are dated within the last 90 days.
- Are IBO insiders net buyers or net sellers?
- Across the full Form 4 history for IBO, 8 transactions (19%) were open-market purchases and 34 (81%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does IBO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is IBO in?
- IMPACT BIOMEDICAL INC. (IBO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $62.84M.
Methodology & sources
Every IBO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.